DCX Learn, the online learning portal of India’s largest and safest cryptocurrency exchange CoinDCX, has announced its partnership with Blockchain Council, the pioneer in online training and ...
DCX Liquid Cooling Systems has launched a new cooling distribution unit (CDU). The company this week announced the new, second-generation facility distribution unit (FDU V2AT2). The new CDU delivers ...
DCX Systems Limited is an Indian company that specializes in the manufacturing of electronic sub-systems and cable harnesses, primarily serving the defence and aerospace sectors. Established in 2011, ...
Fair trade regulator CCI on Tuesday approved US-based cryptocurrency platform Coinbase's proposal to acquire a minority stake in DCX Global Ltd. The development came after Coinbase Global in October ...
The U.S. Department of Energy has selected Arizona State University and DCX USA LLC, as research partners for its Microreactor Application Research Validation and Evaluation (MARVEL) program as a ...
The former Chijet Motor Company (CJET) continues to rally after announcing its name change to Digital Currency X Technology Inc. and new ticker symbol DCX. Due to certain regulatory procedural reasons ...
Gain Skills Business Media proudly concluded the 12th Digital Customer Experience Confex & Awards 2025 - Mumbai Chapter on 10th September 2025 at The Westin Mumbai Garden City, under the central theme ...
From a long-term perspective, we view DCX Systems as structurally well-positioned to benefit from rising defence exports and import substitution initiatives. Its strong order book (2.5x of FY25 ...
Choice Equity Broking has downgraded defence electronics manufacturer DCX Systems Ltd shares from a 'REDUCE' rating to 'SELL' and lowered the target price by 17.98 per cent from Rs 317 to Rs 260. The ...
Repare Therapeutics has entered an out-licensing agreement with Canadian biotechnology firm DCx Biotherapeutics for discovery platforms and intellectual property (IP). Repare will obtain $4m in ...
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that it has out-licensed its ...